Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Gut Microbiome Disruption Following SARS-CoV-2: A Review.
Righi E, Dalla Vecchia I, Auerbach N, Morra M, Górska A, Sciammarella C, Lambertenghi L, Gentilotti E, Mirandola M, Tacconelli E, Sartor A. Righi E, et al. Among authors: lambertenghi l. Microorganisms. 2024 Jan 9;12(1):131. doi: 10.3390/microorganisms12010131. Microorganisms. 2024. PMID: 38257958 Free PMC article. Review.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework.
Carrara E, Grossi PA, Gori A, Lambertenghi L, Antonelli M, Lombardi A, Bongiovanni F; AIFA-OPERA Working Group; Magrini N, Manfredi C, Stefani S, Tumbarello M, Tacconelli E. Carrara E, et al. Among authors: lambertenghi l. Lancet Infect Dis. 2024 Feb;24(2):e113-e126. doi: 10.1016/S1473-3099(23)00435-8. Epub 2023 Sep 4. Lancet Infect Dis. 2024. PMID: 37678308 Review.
Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting.
Azzini AM, Be G, Naso L, Lambertenghi L, Salerno ND, Coledan I, Bazaj A, Mirandola M, Miotti J, Mazzaferri F, Accordini S, Lo Cascio G, Tacconelli E. Azzini AM, et al. Among authors: lambertenghi l. Front Cell Infect Microbiol. 2023 Jun 12;13:1155320. doi: 10.3389/fcimb.2023.1155320. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37377644 Free PMC article.
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study.
Erdem H, Hargreaves S, Ankarali H, Caskurlu H, Ceviker SA, Bahar-Kacmaz A, Meric-Koc M, Altindis M, Yildiz-Kirazaldi Y, Kizilates F, Alsalman J, Cag Y, Kamal AHM, Dokmetas I, Dindar-Demiray EK, Shehata GA, Hasman H, Sadykova A, Llopis F, Ramosaco E, Logar M, Alay H, Kesmez-Can F, Ruch Y, Bulut D, Makek MJ, Marino A, Mahboob A, El-Kholy A, Abdallah D, Sefa-Sayar M, Karaali R, Aslan S, Dar RE, Abdalla E, Monzón-Camps H, Baljić R, Mgdalena DI, Naghili B, Abbas Dafalla ME, Alwashmi ASS, Carmen CR, Ramirez-Estrada S, Wojewodzka-Zelezniakowicz M, Akyildiz O, Zajkowska J, El-Sokkary R, Pandya N, Amer F, Alavi-Darazam I, Grgić S, Wegdan AA, El-Kholy J, Bulut-Avsar C, Kulzhanova S, Tasbakan M, Kumari HP, Dirani N, Koganti K, Konkayev AK, Petrov MM, Cascio A, Liskova A, Del Vecchio RF, Lambertenghi L, Mladenov N, Oncu S, Rello J. Erdem H, et al. Among authors: lambertenghi l. J Chemother. 2021 Sep;33(5):302-318. doi: 10.1080/1120009X.2020.1863696. Epub 2021 Mar 18. J Chemother. 2021. PMID: 33734040
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study.
Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, Ivaldi F, Visentin A, Lambertenghi L, Arena C, Micheletto C, Gibellini D, Tacconelli E. Righi E, et al. Among authors: lambertenghi l. J Infect. 2022 Apr;84(4):566-572. doi: 10.1016/j.jinf.2022.02.003. Epub 2022 Feb 10. J Infect. 2022. PMID: 35150765 Free PMC article.
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test.
Diani E, Piccaluga PP, Lotti V, Di Clemente A, Ligozzi M, De Nardo P, Lambertenghi L, Pizzolo F, Friso S, Lo Cascio G, Vianello A, Marchi G, Concia E, Gibellini D. Diani E, et al. Among authors: lambertenghi l. Heliyon. 2021 Oct;7(10):e08192. doi: 10.1016/j.heliyon.2021.e08192. Epub 2021 Oct 19. Heliyon. 2021. PMID: 34693063 Free PMC article.